Sorrento Therapeutics, Inc. (SRNE)

8.15
1.25 18.12
NASDAQ
Prev Close 6.90
Open 8.28
Day Low/High 7.60 / 8.30
52 Wk Low/High 1.55 / 19.39
Volume 46.64M
Exchange NASDAQ
Shares Outstanding 262.94B
Market Cap 1.81B
P/E Ratio N/A
Div & Yield N.A. (N.A)
Sorrento Therapeutics Stock Is Not That Attractive Now

Sorrento Therapeutics Stock Is Not That Attractive Now

I like to look for more compelling setups.

Market Still Looks Healthy as Fed Stays Steady

Market Still Looks Healthy as Fed Stays Steady

While those with a bearish bent often look for a 'sell the news' reaction to the Fed, that usually doesn't happen, but let's keep watch.

Jim Cramer: The Seven Deadly Stock Sins (as Seen on Twitter)

Jim Cramer: The Seven Deadly Stock Sins (as Seen on Twitter)

Penny stocks are for suckers, and six other rules for better investing -- and tuning out the tweet noise.

Trade Cautiously With Sorrento Therapeutics

Trade Cautiously With Sorrento Therapeutics

Short-term traders may want to nail down profits and be careful in their trading strategy with this name.

Jim Cramer: What Happens in a Bull Market Is That Stocks Move Up on Nothing

Jim Cramer: What Happens in a Bull Market Is That Stocks Move Up on Nothing

Isaac Newton's first lesson: An object in motion stays in motion with the same speed and in the same direction unless acted upon by an unbalanced force.

Jim Cramer: Buyers, It's Time to Look in the Mirror

Jim Cramer: Buyers, It's Time to Look in the Mirror

Blame the Fed? No. I'm reserving my wrath for the clueless buyers who appear to have taken a permanent intellectual summer vacation.

Sorrento Therapeutics Has Made a Large Base Formation - Timing Is Key

Sorrento Therapeutics Has Made a Large Base Formation - Timing Is Key

The question is when to buy and what to risk.

When a Bus Hits the Equity Market, Learn How to Ride With It

When a Bus Hits the Equity Market, Learn How to Ride With It

Here are a couple examples of what traders can do to take advantage of those days when stocks take a shellacking.

Sorrento Therapeutics' Wild Swings Are Something I'd Prefer to Miss

Sorrento Therapeutics' Wild Swings Are Something I'd Prefer to Miss

The biotech's shares run too hot and cold for this technical analyst's tastes.

There's Plenty of Positive Action But It's a Little Overheated

There's Plenty of Positive Action But It's a Little Overheated

I'll be watching for entry points to develop this afternoon.

I'm Not Feeling There's Support for a Bounce Now

I'm Not Feeling There's Support for a Bounce Now

I'm focused on managing positions and am doing very little new buying at this point.

With an Eye on Biotech, Here's Today's Trading Thesis

With an Eye on Biotech, Here's Today's Trading Thesis

It is important to note that watching for a reversal is much different than being short.

Biotech Heats Up as Fear of Missing Out Returns

Biotech Heats Up as Fear of Missing Out Returns

It's hard to believe the bounce will continue to run in V-shaped fashion.

Seeing Good Action in Several Stocks, Buying More MJ, Gold

Seeing Good Action in Several Stocks, Buying More MJ, Gold

It is a very different market environment now which can be very rewarding depending on your style.

Building in Biotech, Adding to Twitter

Building in Biotech, Adding to Twitter

The challenge of this market is to keep finding new buy entries as more and more stocks become extended.

In This Booming Stock Market, Think Like a Programmer Not a Critic

In This Booming Stock Market, Think Like a Programmer Not a Critic

What drives the trading action are structural issues, not macroeconomic news events or political drama.

There Is Still Plenty of Strong, Tradable Action

There Is Still Plenty of Strong, Tradable Action

This market may be extended by just about any measure, but that doesn't mean you should be fighting it.

How Trading Notes Can Increase Your Profits

How Trading Notes Can Increase Your Profits

Inertia is your biggest enemy in this market.

The January Effect Is on Time This Year

The January Effect Is on Time This Year

I continue to believe that biotech and biopharma stocks will outperform in 2018.

Biotechs Rise and Oil Falls

Stocks remain pretty much flat-lined, with the main indices trading in a very narrow range on light volume. In fact, oil is one of today's few real movers, down nearly 3%. Elsewhere in the markets: Foot Locker is getting a little lift after Citigrou...